N/A
Completed N=40
An Analysis of Presentation and Outcome Following Treatment of Pancreatic Endocrine Neoplasms
Source: ClinicalTrials.gov NCT02400996 ↗Enrolled (actual)
40
Serious AEs
15.0%
Results posted
Apr 2015
Primary outcomePrimary: Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms — 28; 12; 22; 18 participants
Summary
A single institutional study of Pancreatic Endocrine Neoplasms over 18 years.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Nonfunctioning and Malignant Pancreatic Endocrine Neoplasms |
28; 12; 22; 18 | — |
Eligibility Criteria
Inclusion Criteria
- Pathological reports and Prooperative CAT Scan showing Endocrine Pancreatic Tumours
Exclusion Criteria
- Nonendocrine Pancreatic Tumours
Data sourced from ClinicalTrials.gov (NCT02400996). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.